EP4720093A2 - Verfahren zur herstellung von peptidkonjugaten und daraus hergestelltes produkt - Google Patents
Verfahren zur herstellung von peptidkonjugaten und daraus hergestelltes produktInfo
- Publication number
- EP4720093A2 EP4720093A2 EP24816508.6A EP24816508A EP4720093A2 EP 4720093 A2 EP4720093 A2 EP 4720093A2 EP 24816508 A EP24816508 A EP 24816508A EP 4720093 A2 EP4720093 A2 EP 4720093A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- peptide
- compound
- seq
- hrc
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363470257P | 2023-06-01 | 2023-06-01 | |
| PCT/US2024/031869 WO2024249765A2 (en) | 2023-06-01 | 2024-05-31 | Methods for making peptide conjugates and the product made therefrom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4720093A2 true EP4720093A2 (de) | 2026-04-08 |
Family
ID=93658727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24816508.6A Pending EP4720093A2 (de) | 2023-06-01 | 2024-05-31 | Verfahren zur herstellung von peptidkonjugaten und daraus hergestelltes produkt |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4720093A2 (de) |
| CN (1) | CN121712791A (de) |
| AU (1) | AU2024278914A1 (de) |
| WO (1) | WO2024249765A2 (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993022343A1 (en) * | 1992-05-01 | 1993-11-11 | The Rockfeller University | Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom |
| WO2022159372A1 (en) * | 2021-01-22 | 2022-07-28 | Decoy Therapeutics, Inc. | Methods and compositions for treating infections |
-
2024
- 2024-05-31 CN CN202480049857.4A patent/CN121712791A/zh active Pending
- 2024-05-31 EP EP24816508.6A patent/EP4720093A2/de active Pending
- 2024-05-31 AU AU2024278914A patent/AU2024278914A1/en active Pending
- 2024-05-31 WO PCT/US2024/031869 patent/WO2024249765A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024249765A3 (en) | 2025-03-13 |
| WO2024249765A2 (en) | 2024-12-05 |
| AU2024278914A1 (en) | 2026-01-15 |
| CN121712791A (zh) | 2026-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parray et al. | Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections | |
| ES3002666T3 (en) | Improved peptide pharmaceuticals for treatment of nash and other disorders | |
| US8299214B2 (en) | Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent | |
| US20250387468A1 (en) | Methods and Compositions for Treating Infections | |
| ES3053993T3 (en) | Optimised compounds | |
| JP2026000993A (ja) | 新ペプチド | |
| CN103200955A (zh) | 包含肽和病毒神经氨酸酶抑制剂的组合物 | |
| CN120699110B (zh) | 一种抗rsv的多肽膜融合抑制剂及其制备方法和用途 | |
| EP4720093A2 (de) | Verfahren zur herstellung von peptidkonjugaten und daraus hergestelltes produkt | |
| US20240108735A1 (en) | Methods and compositions for treating covid infections | |
| JP2025505673A (ja) | Covid感染症を処置するための方法および組成物 | |
| ES2337663T3 (es) | Compuestos peptidicos que se unen selectivamente a p-selectina. | |
| AU2018284219A1 (en) | Hydrochloride salts of C5a receptor agonist peptides | |
| US20240366712A1 (en) | Griffithsin for use in a method of preventing or treating infections with respiratory viruses | |
| US20260077052A1 (en) | Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmission | |
| JP2002012555A (ja) | インフルエンザ予防剤 | |
| AU2021278137A1 (en) | Pharmaceutical composition comprising polynucleotides and use thereof for prevention or treatment of COVID-19 | |
| WO2001080892A1 (en) | Preventives for influenza | |
| WO2025231182A9 (en) | New formulation of antiviral peptide conjugates | |
| CN114989259A (zh) | 一种小分子肽Ped4及应用 | |
| HK40083799A (en) | Clofazimine composition and method for the treatment or prophylaxis of viral infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251229 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |